Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bangkok Drug is a prominent Thai pharmaceutical company dedicated to the development, production, and marketing of generic and branded generic medicines. Established in 1989, the company operates advanced manufacturing facilities in Samut Prakan that adhere to international PIC/S GMP standards. Their diverse product portfolio spans multiple therapeutic areas, including cardiovascular health, metabolic disorders, respiratory diseases, and gastrointestinal care. As a key player in the Southeast Asian healthcare market, Bangkok Drug focuses on providing high-quality, affordable alternatives to off-patent medications. The company maintains a strong distribution network through its affiliate, B.L.H. Trading, ensuring widespread access to its products across hospitals and pharmacies. Through continuous investment in research and development, Bangkok Drug remains committed to improving patient outcomes and supporting the regional healthcare infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bangkok Drugs.